Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task
暂无分享,去创建一个
[1] T. Rao,et al. Effects of a novel cholinergic ion channel agonist SIB-1765F on locomotor activity in rats. , 1997, The Journal of pharmacology and experimental therapeutics.
[2] H. Fibiger,et al. Cholinergic activity in the rat hippocampus, cortex and striatum correlates with locomotor activity: An in vivo microdialysis study , 1991, Pharmacology Biochemistry and Behavior.
[3] H. Fibiger,et al. Increases in hippocampal and frontal cortical acetylcholine release associated with presentation of sensory stimuli , 1995, Neuroscience.
[4] E. Levin,et al. Nicotinic System Involvement in Alzheimer’s and Parkinson’s Diseases , 1997, Drugs & aging.
[5] S J Heishman,et al. What aspects of human performance are truly enhanced by nicotine? , 1998, Addiction.
[6] B. Hahn,et al. Nicotine in an animal model of attention. , 2000, European journal of pharmacology.
[7] Andrew P. Smith,et al. Noradrenaline and attention lapses , 1996, Nature.
[8] D.N.C. Jones,et al. Age-associated impairments in a test of attention: evidence for involvement of cholinergic systems , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[9] A. C. Collins,et al. UB-165: A Novel Nicotinic Agonist with Subtype Selectivity Implicates the α4β2* Subtype in the Modulation of Dopamine Release from Rat Striatal Synaptosomes , 2000, The Journal of Neuroscience.
[10] T. Robbins,et al. Neural Systems Underlying Arousal and Attention: Implications for Drug Abuse a , 1998, Annals of the New York Academy of Sciences.
[11] I. Stolerman,et al. The role of nicotinic and muscarinic acetylcholine receptors in attention , 2000, Psychopharmacology.
[12] B. Martin. Nicotine Receptors in the Central Nervous System , 1986 .
[13] G. Higgins,et al. Evidence that nicotinic alpha(7) receptors are not involved in the hyperlocomotor and rewarding effects of nicotine. , 2000, The Journal of pharmacology and experimental therapeutics.
[14] Ian P. Stolerman,et al. Nicotine enhances sustained attention in the rat under specific task conditions , 1998, Psychopharmacology.
[15] E. Levin,et al. AR-R 17779, an α7 nicotinic agonist, improves learning and memory in rats , 1999 .
[16] P. Clarke,et al. Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons , 1985, Brain Research.
[17] J. McCarten,et al. Nicotine patches in Alzheimer's disease: Pilot study on learning, memory, and safety , 1995, Pharmacology Biochemistry and Behavior.
[18] J. Changeux,et al. Pathological mutations of nicotinic receptors and nicotine-based therapies for brain disorders , 1997, Current Opinion in Neurobiology.
[19] T. Robbins,et al. Doubly dissociable effects of median- and dorsal-raphé lesions on the performance of the five-choice serial reaction time test of attention in rats , 1997, Behavioural Brain Research.
[20] C. Luetje,et al. Determinants of Competitive Antagonist Sensitivity on Neuronal Nicotinic Receptor β Subunits , 1996, The Journal of Neuroscience.
[21] P. Adams,et al. Pharmacological characterization of SIB-1765F: a novel cholinergic ion channel agonist. , 1997, The Journal of pharmacology and experimental therapeutics.
[22] T. Robbins,et al. Comparative effects of ibotenic acid- and quisqualic acid-induced lesions of the substantia innominata on attentional function in the rat: further implications for the role of the cholinergic neurons of the nucleus basalis in cognitive processes , 1989, Behavioural Brain Research.
[23] P. Clarke,et al. Characterization of the locomotor stimulant action of nicotine in tolerant rats , 1983, British journal of pharmacology.
[24] T. Robbins,et al. Central cholinergic systems and cognition. , 1997, Annual review of psychology.
[25] D. Warburton,et al. Evaluation of the information processing and mood effects of a transdermal nicotine patch , 1998, Psychopharmacology.
[26] E. Levin,et al. Transdermal nicotine effects on attention , 1998, Psychopharmacology.
[27] J. Rusted,et al. Effortful processing is a requirement for nicotine-induced improvements in memory , 1998, Psychopharmacology.
[28] Barry J. Everitt,et al. Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanisms , 1997, Psychopharmacology.
[29] Ezio Tirelli,et al. Selective effects of nicotine on attentional processes , 1999, Psychopharmacology.
[30] B. Everitt,et al. AMPA-induced excitotoxic lesions of the basal forebrain: a significant role for the cortical cholinergic system in attentional function , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[31] E. Levin,et al. Nicotinic acetylcholine involvement in cognitive function in animals , 1998, Psychopharmacology.
[32] B. Potter,et al. Characterisation of the binding of [3H]methyllycaconitine: a new radioligand for labelling α7-type neuronal nicotinic acetylcholine receptors , 1999, Neuropharmacology.
[33] Trevor W. Robbins,et al. Effects of 6-hydroxydopamine lesions of the nucleus accumbens septi on performance of a 5-choice serial reaction time task in rats: Implications for theories of selective attention and arousal , 1989, Behavioural Brain Research.
[34] Agneta Nordberg,et al. Neuronal nicotinic receptors in the human brain , 2000, Progress in Neurobiology.
[35] D. Sanger,et al. The effect of repeated nicotine administration on the performance of drug-naive rats in a five-choice serial reaction time task. , 1999, Behavioural pharmacology.
[36] E. Levin,et al. Nicotine–Haloperidol Interactions and Cognitive Performance in Schizophrenics , 1996, Neuropsychopharmacology.
[37] L. Wilkinson,et al. Visuospatial attentional functioning in mice: interactions between cholinergic manipulations and genotype , 1999, The European journal of neuroscience.
[38] T. Robbins,et al. Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal , 1983, Behavioural Brain Research.
[39] J. Changeux,et al. Nicotinic acetylcholine receptor knockout mice as animal models for studying receptor function. , 2000, European journal of pharmacology.
[40] M. Delong,et al. A reappraisal of the functions of the nucleus basalis of Meynert , 1988, Trends in Neurosciences.
[41] L. Epstein,et al. Conditioned tolerance to the heart rate effects of smoking , 1991, Pharmacology Biochemistry and Behavior.
[42] L. Role,et al. Nicotinic Receptors in the Development and Modulation of CNS Synapses , 1996, Neuron.
[43] P. Soubrié,et al. A simple model for studying benzodiazepines: Potentiation of hyperactivity induced by cocaine in mice , 1982 .
[44] J. Sirviö,et al. Blockade of muscarinic, rather than nicotinic, receptors impairs attention, but does not interact with serotonin depletion , 2000, Psychopharmacology.
[45] J. McIntosh,et al. α-Conotoxin MII Blocks Nicotine-Stimulated Dopamine Release in Rat Striatal Synaptosomes , 1997, The Journal of Neuroscience.
[46] D. Sanger,et al. Characterisation of the effects of nicotine in the five-choice serial reaction time task in rats: antagonist studies , 2000, Psychopharmacology.
[47] P. Clarke,et al. The effects of nicotine on locomotor activity in non‐tolerant and tolerant rats , 1983, British journal of pharmacology.
[48] B. Christensen,et al. Mecamylamine is a selective non-competitive antagonist of N-methyl-d-aspartate- and aspartate-induced currents in horizontal cells dissociated from the catfish retina , 1988, Neuroscience Letters.
[49] H. Fibiger,et al. Enhanced acetylcholine release in hippocampus and cortex during the anticipation and consumption of a palatable meal , 1994, Neuroscience.
[50] B. Sahakian,et al. The Effects of Nicotine on Attention, Information Processing, and Short-Term Memory in Patients with Dementia of the Alzheimer Type , 1989, British Journal of Psychiatry.
[51] P. Sanberg,et al. Nicotine for the treatment of Tourette's syndrome. , 1997, Pharmacology & therapeutics.
[52] J. Muir,et al. The cerebral cortex of the rat and visual attentional function: dissociable effects of mediofrontal, cingulate, anterior dorsolateral, and parietal cortex lesions on a five-choice serial reaction time task. , 1996, Cerebral cortex.
[53] E. Levin,et al. Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer’s disease , 1999, Psychopharmacology.
[54] M. Benwell,et al. The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity , 1992, British journal of pharmacology.
[55] E D Levin,et al. Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD). , 1996, Psychopharmacology bulletin.
[56] Bradley V. Clineschmidt,et al. Central sympathomimetic activity of (+)‐5‐methyl‐10,11‐dihydro‐5H‐dibenzo [a, d]cyclohepten‐5,10‐imine (MK‐801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties , 2022 .
[57] G. Koob,et al. Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects. , 2000, The Journal of pharmacology and experimental therapeutics.
[58] J. Rusted,et al. Cholinergic control of cognitive resources. , 1993, Neuropsychobiology.
[59] I. Stolerman. Inter-species consistency in the behavioural pharmacology of nicotine dependence. , 1999, Behavioural pharmacology.
[60] I. Stolerman,et al. Selective antagonism of behavioural effects of nicotine by dihydro-β-erythroidine in rats , 1997, Psychopharmacology.
[61] J P Changeux,et al. International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. , 1999, Pharmacological reviews.
[62] E. Rolls,et al. Neuronal responses related to reinforcement in the primate basal forebrain , 1990, Brain Research.